Alterations in cytokine but not chemokine mRNA expression during three distinct Theiler's virus infections

Journal of Neuroimmunology

Volumn 104, Issue 1, 2000, Pages 22-30

  Theil, Diethilde J ^a   Tsunoda, Ikuo ^a   Libbey, Jane E ^a   Derfuss, Tobias J ^a   Fujinami, Robert S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Chemokines; Cytokines; Encephalomyelitis; TMEV

Indexed keywords

BETA INTERFERON; CHEMOKINE; CYTOKINE; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMYELINATING DISEASE; ENCEPHALOMYELITIS; FEMALE; HYDROCEPHALUS; IMMUNE RESPONSE; MENINGITIS; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION;

ANIMALS; CARDIOVIRUS INFECTIONS; CHEMOKINES; CYTOKINES; FEMALE; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MICE; NUCLEIC ACID HYBRIDIZATION; RATS; RATS, INBRED STRAINS; RIBONUCLEASES; RNA, MESSENGER; SPECIES SPECIFICITY; THEILOVIRUS;

EID: 0033952574     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00251-9     Document Type: Article

References (36)

1. Asensio V.C., Campbell I.L. Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis. J. Virol. 71:1997;7832-7840.
2. Barten D.M., Ruddle N.H. Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis. J. Neuroimmunol. 51:1994;123-133.
3. Carlos T.M., Schwartz B.R., Kovach N.L., Yee E., Rosa M., Osborn L., Chi-Rosso G., Newman B., Lobb R., Harlan J.M. Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood. 76:1990;965-970.
4. Dal Canto M.C., Lipton H.L. Multiple sclerosis. Animal model: Theiler's virus infection in mice. Am. J. Pathol. 88:1977;497-500.
5. Daniels J.B., Pappenheimer A.M., Richardson S. Observations on encephalomyelitis of mice (DA strain). J. Exp. Med. 96:1952;517-535.
6. Dhib-Jalbut S.S., Xia Q., Drew P.D., Swoveland P.T. Differential up-regulation of HLA class I molecules on neuronal and glial cell lines by virus infection correlates with differential induction of IFN-beta. J. Immunol. 155:1995;2096-2108.
7. Dopp J.M., Breneman S.M., Olschowka J.A. Expression of ICAM-1, VCAM-1, L-selectin, and leukosialin in the mouse central nervous system during the induction and remission stages of experimental allergic encephalomyelitis. J. Neuroimmunol. 54:1994;129-144.
8. Fabry Z., Waldschmidt M.M., Hendrickson D., Keiner J., Love H.L., Takei F., Hart M.N. Adhesion molecules on murine brain microvascular endothelial cells: expression and regulation of ICAM-1 and Lgp 55. J. Neuroimmunol. 36:1992;1-11.
9. Fiette L., Aubert C., Müller U., Huang S., Aguet M., Brahic M., Bureau J.-F. Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors. J. Exp. Med. 181:1995;2069-2076.
10. Hofman F.M., Hinton D.R., Johnson K., Merrill J.E. Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170:1989;607-612.
11. Körner H., Sedgwick J.D. Tumour necrosis factor and lymphotoxin: Molecular aspects and role in tissue-specific autoimmunity. Immunol. Cell Biol. 74:1996;465-472.
12. Kratz A., Campos-Neto A., Hanson M.S., Ruddle N.H. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J. Exp. Med. 183:1996;1461-1472.
13. Lane T.E., Asensio V.C., Yu N., Paoletti A.D., Campbell I.L., Buchmeier M.J. Dynamic regulation of α- and β-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J. Immunol. 160:1998;970-978.
14. Lipton H.L. Persistent Theiler's murine encephalomyelitis virus infection in mice depends on plaque size. J. Gen. Virol. 46:1980;169-177.
15. McManus C., Berman J.W., Brett F.M., Staunton H., Farrell M., Brosnan C.F. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study. J. Neuroimmunol. 86:1998;20-29.
16. Miyagishi R., Kikuchi S., Takayama C., Inoue Y., Tashiro K. Identification of cell types producing RANTES, MIP-1 α and MIP-1 β in rat experimental autoimmune encephalomyelitis by in situ hybridization. J. Neuroimmunol. 77:1997;17-26.
17. + T lymphocytes provide protection against TMEV-induced demyelinating disease in BALB/c mice. J. Immunol. 156:1996;1276-1283.
18. Oh J.W., Van Wagoner N.J., Rose John S., Benveniste E.N. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression. J. Immunol. 161:1998;4992-4999.
19. Panitch H.S., Bever C.T. Jr. Clinical trials of interferons in multiple sclerosis. What have we learned? J. Neuroimmunol. 46:1993;155-164.
20. Paul N.L., Ruddle N.H. Lymphotoxin. Annu. Rev. Immunol. 6:1988;407-438.
21. Perry V.H. A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation. J. Neuroimmunol. 90:1998;113-121.
22. Powell M.B., Mitchell D., Lederman J., Buckmeier J., Zamvil S.S., Graham M., Ruddle N.H., Steinman L. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int. Immunol. 2:1990;539-544.
23. Ransohoff R.M., Hamilton T.A., Tani M., Stoler M.H., Shick H.E., Major J.A., Estes M.L., Thomas D.M., Tuohy V.K. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J. 7:1993;592-600.
24. Ruddle N.H., Bergman C.M., McGrath K.M., Lingenheld E.G., Grunnet M.L., Padula S.J., Clark R.B. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1990;1193-1200.
25. Sacca R., Kratz A., Campos-Neto A., Hanson M.S., Ruddle N.H. Lymphotoxin: from chronic inflammation to lymphoid organs. J. Inflamm. 47:1995;81-84.
26. Schuchmann M., Hess S., Bufler P., Brakebusch C., Wallach D., Porter A., Riethmuller G., Engelmann H. Functional discrepancies between tumor necrosis factor and lymphotoxin alpha explained by trimer stability and distinct receptor interactions. Eur. J. Immunol. 25:1995;2183-2189.
27. Selmaj K., Raine C.S., Farooq M., Norton W.T., Brosnan C.F. Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J. Immunol. 147:1991;1522-1529.
28. Tada T., Kanaji M., Kobayashi S. Induction of communicating hydrocephalus in mice by intrathecal injection of human recombinant transforming growth factor-β 1. J. Neuroimmunol. 50:1994;153-158.
29. Theiler M. Spontaneous encephalomyelitis of mice: a new virus disease. Science. 80:1934;122.
30. Theiler M. Spontaneous encephalomyelitis of mice, a new virus disease. J. Exp. Med. 65:1937;705-719.
31. Theiler M., Gard S. Encephalomyelitis of mice. III. Epidemiology. J. Exp. Med. 72:1940;79-90.
32. Tsunoda I., McCright I.J., Kuang L.-Q., Zurbriggen A., Fujinami R.S. Hydrocephalus in mice infected with a Theiler's murine encephalomyelitis virus variant. J. Neuropathol. Exp. Neurol. 56:1997;1302-1313.
33. Van den Broek M.F., Müller U., Huang S., Zinkernagel R.M., Aguet M. Immune defence in mice lacking type I and/or type II interferon receptors. Immunol. Rev. 148:1995;5-18.
34. Ward L.A., Massa P.T. Neuron-specific regulation of major histocompatibility complex class I, interferon-beta, and anti-viral state genes. J. Neuroimmunol. 58:1995;145-155.
35. Ward S.G., Bacon K., Westwick J. Chemokines and T lymphocytes: More than an attraction. Immunity. 9:1998;1-11.
36. Wyss-Coray T., Feng L., Masliah E., Ruppe M.D., Lee H.S., Toggas S.M., Rockenstein E.M., Mucke L. Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-beta 1. Am. J. Pathol. 147:1995;53-67.